In a recent study published in Small, researchers at the University of Michigan developed nanodiscs designed to target ...

A man has become the first in the world to join the new part of a brain cancer trial in Leeds. Ian Johnson, 50, is taking ...

Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

Medicine evolves, and it evolves because of these people.” In all, Lewandowski underwent 33 days of radiation and more than a year of chemotherapy. Did it work? Angels Among Us raises money for the ...

The Third International Conference on Applications of Radiation Science and Technology (ICARST-2025) builds on the success of its predecessors in 2017 and 2022. The purpose of the event is to: provide ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

You have a brain tumor, and we think it's cancer.’ “So it was immediately, like, ‘Wow,’” he continues. His mother and brother came to the hospital, and they were all stunned — and knew ...

How would you describe the current state of radiotherapy in India? What are the major challenges faced by the radiotherapy sector in India? Response: India is witnessing a leap in cancer care thanks ...

The radiotherapy and hemodialysis centre in Granollers, Spain, designed by Baas and Casa Solo, is an elegant alternative to sterile healthcare architecture While hospitals naturally require particular ...

Image credit: Nemes Laszlo / Shutterstock. A new study has confirmed that a molecular diagnostic test developed by MiraDx can predict the side effects of radiation therapy in prostate cancer patients ...

The authors confirm that the absence of the asterisks does not negatively affect the understanding of the data or lead to any misinterpretation, as the statistical significance of the findings is ...

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival ...